CVRx Raises $75M In IPO To Commercialize And Develop Heart Failure Therapy

 
• By Reed Miller

The funds will support expanded commercialization of the company’s baroreflex activation stimulation technology to treat heart failure in patients with a low left-ventricular ejection fraction.

NASDAQ building in Time Square at night - Image ID: 2AF6DBG
• Source: Alamy

More from Financing

More from Business